Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Jurutka

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 31, 2019
Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMNPeter W Jurutka, Carl E Wagner
Methods in Molecular Biology (Clifton, N.J.)|July 31, 2019
Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMNCarl E Wagner, Peter W Jurutka
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2011
Vitamin D: marker or mechanism of action?Elizabeth T Jacobs, María Elena Martínez, Peter W Jurutka
Vitamins and Hormones|September 17, 2023
Genomically anchored vitamin D receptor mediates an abundance of bioprotective actions elicited by its 1,25-dihydroxyvitamin D hormonal ligandMark R Haussler, Carol A Haussler, Peter W Jurutka
Current Topics in Medicinal Chemistry|January 25, 2017
EDITORIAL (Thematic Issue : Rexinoids)Carl E Wagner, Pamela A Marshall, Peter W Jurutka
Best Practice & Research. Clinical Endocrinology & Metabolism|August 30, 2011
Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanismsMark R Haussler, Peter W Jurutka, Mathew Mizwicki, et al.
Current Topics in Medicinal Chemistry|June 21, 2016
Retinoid X Receptor Selective Agonists and their Synthetic MethodsCarl E Wagner, Peter W Jurutka, Pamela A Marshall, et al.
Journal of Cancer|February 27, 2016
Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological EvidenceElizabeth T Jacobs, Lindsay N Kohler, Andrew G Kunihiro, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2009
Vitamin D, calcium, and colorectal neoplasia: new insights on mechanisms of actionElizabeth T Jacobs, Peter W Jurutka, María Elena Martínez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasiaElizabeth A Hibler, Chengcheng Hu, Peter W Jurutka, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Methods in Molecular Biology (Clifton, N.J.)|July 31, 2019
Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMNPeter W Jurutka, Carl E Wagner
Methods in Molecular Biology (Clifton, N.J.)|July 31, 2019
Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMNCarl E Wagner, Peter W Jurutka
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2011
Vitamin D: marker or mechanism of action?Elizabeth T Jacobs, María Elena Martínez, Peter W Jurutka
Vitamins and Hormones|September 17, 2023
Genomically anchored vitamin D receptor mediates an abundance of bioprotective actions elicited by its 1,25-dihydroxyvitamin D hormonal ligandMark R Haussler, Carol A Haussler, Peter W Jurutka
Current Topics in Medicinal Chemistry|January 25, 2017
EDITORIAL (Thematic Issue : Rexinoids)Carl E Wagner, Pamela A Marshall, Peter W Jurutka
Best Practice & Research. Clinical Endocrinology & Metabolism|August 30, 2011
Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanismsMark R Haussler, Peter W Jurutka, Mathew Mizwicki, et al.
Current Topics in Medicinal Chemistry|June 21, 2016
Retinoid X Receptor Selective Agonists and their Synthetic MethodsCarl E Wagner, Peter W Jurutka, Pamela A Marshall, et al.
Journal of Cancer|February 27, 2016
Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological EvidenceElizabeth T Jacobs, Lindsay N Kohler, Andrew G Kunihiro, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2009
Vitamin D, calcium, and colorectal neoplasia: new insights on mechanisms of actionElizabeth T Jacobs, Peter W Jurutka, María Elena Martínez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasiaElizabeth A Hibler, Chengcheng Hu, Peter W Jurutka, et al.
Pageof 9